Li Zheng

Li Zheng is a Senior Scientist 1 at Eikon Therapeutics working in medicinal chemistry. Prior to this role, Li was a Postdoctoral Scholar at Stanford University with a joint appointment in Stanford ChEM-H Medicinal Chemistry Knowledge Center and School of Medicine. Li's research focuses on small molecule drug discovery for the treatment of diabetes and neuroendocrine tumors. Li has a Doctor of Philosophy in Organic Chemistry from Michigan State University and a Bachelor of Science in Chemistry from Nanjing University.